1 |
Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2021, 7(1): 6.
|
2 |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
3 |
Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches[J]. Biochim Biophys Acta Rev Cancer, 2020, 1873(1): 188314.
|
4 |
Demir T, Lee SS, Kaseb AO. Systemic therapy of liver cancer[J]. Adv Cancer Res, 2021, 149:257-294.
|
5 |
Maki H, Hasegawa K. Advances in the surgical treatment of liver cancer[J]. Biosci Trends, 2022, 16(3): 178-188.
|
6 |
Izzo F, Granata V, Grassi R, et al. Radiofrequency ablation and microwave ablation in liver tumors: an update[J]. Oncologist, 2019, 24(10): 990-1005.
|
7 |
Liu W, Zou R, Wang C, et al. Microwave ablation resection for hepatocellular carcinoma within the milan criteria: a propensity-score analysis[J]. Therapeutic Advances In Medical Oncology, 2019, 11:1758835919874652.
|
8 |
Liu Y, Zheng J, Hao J, et al. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019[J]. Cancer Med, 2022, 11(5): 1310-1323.
|
9 |
Yang J, Pan G, Guan L, et al. The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels[J]. Cancer Med, 2022, 11(5): 1357-1370.
|
10 |
Soulen MC, Garcia-Monaco R. Closing the gap in curative ablation of liver cancer[J]. Radiology, 2021, 301(1): 237-238.
|
11 |
Wang Z, Liu M, Zhang DZ, et al. Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5 cm HCC[J]. Hepatology (Baltimore, Md), 2022, 76(1): 66-77.
|
12 |
Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms[J]. Int J Hyperthermia, 2018, 34(6): 863-869.
|
13 |
Delmas L, Koch G, Cazzato RL, et al. Artificial ascites using the guidewire technique during microwave ablation in the liver dome: technique and analysis of fluid repartition[J]. Abdom Radiol (NY), 2021, 46(9): 4452-4459.
|
14 |
Ding H, Su M, Zhu C, et al. CT-guided versus laparoscopic radiofrequency ablation in recurrent small hepatocellular carcinoma against the diaphragmatic dome[J]. Sci Rep, 2017, 7:44583.
|
15 |
Long Y, Zeng Q, He X, et al. One-lung ventilation for percutaneous thermal ablation of liver tumors in the hepatic dome[J]. Int J Hyperthermia, 2020, 37(1): 49-54.
|
16 |
Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma[J]. Lancet (London, England), 2022, 400(10360): 1345-1362.
|
17 |
王兆海,王子政,赵国栋. 个体化解剖标志在肝脏肿瘤靶域切除技术中的意义[J/CD]. 中华腔镜外科杂志(电子版), 2022, 15(4):197-200.
|
18 |
刘荣,汪洋. 恶性肿瘤的靶域切除技术[J]. 中华肿瘤杂志,2022, 44(7):725-727.
|
19 |
赵国栋,马奔,刘荣. 肝脏流域学说下的控血新理念:适时分合肝脏控血技术[J]. 中华医学杂志,2021, 101(40):3261-3265.
|
20 |
Xu Z, Xie H, Zhou L, et al. The combination strategy of transarterial chemoembolization and radiofrequency ablation or microwave ablation against hepatocellular carcinoma[J]. Anal Cell Pathol (Amst), 2019, 2019:8619096.
|
21 |
Wei J, Cui W, Fan W, et al. Unresectable hepatocellular carcinoma: transcatheter arterial chemoembolization combined with microwave ablation vs. combined with cryoablation[J]. Frontiers In Oncology, 2020, 10:1285.
|